Dressings in Wisconsin

MedDev is a healthcare technology company specializing in regenerative medicine and advanced wound care solutions. The company distributes biologic skin substitutes based on amniotic membrane technology, designed to accelerate healing in chronic wounds, burn wounds, ophthalmic applications, and surgical procedures. Their product portfolio includes multiple branded skin substitute lines (XCell, XCellerate, Royal Wound, Precise, Royal Bio, BioLab, DermMax, and EnColl). Beyond product distribution, MedDev provides integrated practice optimization services including revenue cycle management, workflow efficiency enhancement, administrative burden reduction, and scheduling optimization. The company serves healthcare providers, clinical partners, and distributors across the United States. MedDev's regenerative solutions leverage amniotic membrane grafts containing growth factors and cytokines to promote cell proliferation, tissue regeneration, inflammatory modulation, and minimal immune response. The company emphasizes compliance-first operations, clinical research backing, and hands-on provider support. Their business model combines premium biologic products with comprehensive practice management services to optimize both patient outcomes and provider operations.

TIDI Products, LLC is a US-based manufacturer and supplier of single-use medical products and protective solutions for healthcare systems, ambulatory surgery centers, long-term care facilities, and independent practices. The company operates a diversified portfolio of brands including Posey (patient safety and restraints), C-Armor (radiation protection), Sterile-Z (sterilization wraps and drapes), Grip Lok (securement devices), TIDI Shield (protective eyewear and face shields), Zero-Gravity (radiation protection apparel), Aquaguard (shower protection), and Burlington Medical (acquired 2024, expanding safety solutions). Product lines span personal protective equipment (PPE), eyewear, face shields, surgical equipment drapes and covers, falls prevention systems, patient restraints and restraint alternatives, securement devices, medical office and dental office products, shower protection, and home healthcare solutions. TIDI's portfolio addresses caregiver protection through barriers against biological and radiological hazards, and patient safety through fall prevention, contamination control, and dignity-preserving solutions. The company emphasizes clinical collaboration, responsive customer support, and continuing education through TIDI Academy. Headquarters in Neenah, Wisconsin; operates nationwide distribution and rep network.

Imbed Biosciences Inc. is a privately held medical device manufacturer headquartered in Middleton, Wisconsin, specializing in advanced wound care solutions. The company develops and markets the SAM™ (Synthetic Antimicrobial Matrix) platform technology—a patented, fully synthetic, biocompatible, bioresorbable matrix designed to integrate multiple wound care agents into an ultra-thin polymer formulation. The SAM™ technology is non-toxic, broad-spectrum antimicrobial through integrated silver, and naturally conforms to wound bed anatomy. Current product portfolio includes Surgaflex™ (acute and surgical wounds), Pelashield™ (burn wounds), and Microlyte® (chronic wounds). Recent portfolio expansion includes SAM™ PainGuard™ variants (Surgaflex™ PainGuard™, Pelashield™ PainGuard™, Microlyte® PainGuard™) that incorporate lidocaine HCl for non-opioid localized pain management alongside antimicrobial protection. Products are indicated for chronic ulcers, surgical wounds, traumatic injuries, and burn wounds across multiple care settings including hospitals, ambulatory surgery centers, physician offices, burn centers, and wound centers. Imbed is registered with the U.S. FDA as a medical device manufacturer and maintains ISO 13485:2016 certification. The company actively supports healthcare providers through education, testimonials, and industry engagement, with recent CMS HCPCS code assignment (A2040) for Microlyte® PainGuard™ enabling standardized billing and claims reporting.

Curapep LLC is a biotechnology company specializing in advanced wound and skin care solutions. The company develops science-driven therapies addressing unmet needs in wound healing and dermatological conditions. Curapep's core offering centers on Oxygen Boost Technology, a proprietary platform designed to create a moist, oxygen-rich microenvironment that supports tissue repair and regeneration. The company's flagship product is Vitynex™ Cream, a topical wound care formulation utilizing advanced peptide technology intended for soothing, healing, and regenerating damaged tissue. The company also offers VityPatch™ Hydrogel, an advanced hydrogel dressing engineered to maintain wound moisture while optimizing oxygen diffusion and supporting autolytic debridement. Curapep's development pipeline includes CP-104, a small-molecule therapeutic currently in development targeting diabetic ulcers and chronic wounds. The company targets healthcare professionals, wound care specialists, dermatologists, and institutions managing chronic wounds, pressure ulcers, diabetic foot ulcers, and post-procedural wounds. Founded by Prof. Amor Khachemoune (dermatology and Mohs surgery expert), Dr. Selim (biology and drug/device design specialist), and Dr. Larry Shimp (biomaterials expert with over 30 years' experience), Curapep emphasizes clinical rigor, scientific excellence, and patient-centered outcomes. The company actively recruits distributors nationwide and markets its products through e-commerce channels. Regulatory status and specific FDA clearances are not detailed on the website.